Comparison of central gastric antisecretory effects of desmethylimipramine, doxepin and pirenzepine in rats.
Certain tricyclic drugs, some of which are primarily used clinically as antidepressants, have been shown to act as gastric antisecretory agents. The anatomical site(s) and mechanism(s) of action of these agents is, however, in most cases unclear. In this study, we found that desmethylimipramine (DMI) was approximately 28 times more potent in inhibiting gastric acid secretion when administered intracerebroventricularly (i.c.) than when administered intravenously (i.v.) in pylorus-ligated rats, which is indicative of a site of action in the central nervous system. Qualitatively similar results were obtained with pirenzepine where the i.c./i.v. potency ratio was 8. Doxepin also preferentially inhibited acid secretion when given i.c. at low but not at high doses. Atropine and chlorpromazine were equipotent antisecretory agents by both routes of administration. Doxepin and DMI but not pirenzepine were effective inhibitors of brain stem norepinephrine uptake in vitro thus making this an unlikely common mechanism to explain the central actions of these compounds.
D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology*; D004316:Doxepin / Q000494:pharmacology*; D005744:Gastric Acid / Q000378:metabolism*; D008297:Male; D010890:Pirenzepine; D051381:Rats; D011919:Rats, Inbred Strains
D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D004316:Doxepin; D010890:Pirenzepine; D001285:Atropine; D003891:Desipramine; D002746:Chlorpromazine